MRI in pharmaceutical safety assessment

In Vivo MR Techniques in Drug Discovery and Development

Volumn , Issue , 2006, Pages 537-554

  Reid, David ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 50149120885     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (65)

1. Klaassen, C. D., Ed., Casarett & Doull’s Toxicology, 6th ed., McGraw-Hill, New York, 2004.
2. Gopinath, C., Prentice, D. E., and Lewis, D. J., Atlas of experimental toxicological pathology, Current Histopathology Series, Vol. 13, Gresham, G. A., Ed., MTP Press, Lancaster, 1987.
3. Dixon, D. et al., Magnetic resonance imaging (MRI): a new tool in experimental toxicologic pathology, Toxicol. Pathol., 16, 386, 1988.
4. Delnomdedieu, M. et al., Magnetic resonance microscopy-a new tool for the toxicologic pathologist, Toxicol. Pathol., 24, 36, 1996.
5. Hazle, J. D., Narayana, P. A., and Dunsford, H. A., Chronic carbon tetrachloride and phospholipase D hepatotoxicity in rat: in vivo 1H magnetic resonance, total lipid analysis, and histology, Magn. Reson. Med., 15, 211, 1990.
6. Towner, R. A. et al., MRI study of the inhibitory effect of new spin traps on in vivo CCl4-induced hepatotoxicity in rats, Free Radic. Biol. Med., 14, 677, 1993.
7. Towner, R. A. et al., In vivo magnetic resonance imaging study of Kupffer cell involvement in CCl4-induced hepatotoxicity in rats, Can. J. Physiol Pharmacol., 72, 441, 1994.
8. Towner, R. A. et al., Enhancement of carbon tetrachloride-induced liver injury by a single dose of ethanol: proton magnetic resonance imaging (MRI) studies in vivo, Biochim. Biophys. Acta, 1096, 222, 1991.
9. Sidhu, M. K. et al., Manganese dipyridoxal diphosphate-enhanced magnetic resonance imaging in the evaluation of hepatocyte function, Invest Radiol., 28, 903, 1993.
10. Zhou, X. et al., Studies on bromobenzene-induced hepatotoxicity using in vivo MR microscopy with surgically implanted RF coils, Magn. Reson. Med., 31, 619, 1994.
11. Kreft, B. et al., Diagnostic value of a superparamagnetic iron oxide in MR imaging of chronic liver disease in an animal model, Am. J. Roentgenol., 170, 661, 1998.
12. Sturgeon, S. A. and Towner, R. A., In vivo assessment of microcystin-LR-induced hepatotoxicity in the rat using proton nuclear magnetic resonance (1H-NMR) imaging, Biochim. Biophys. Acta, 1454, 227, 1999.
13. Kreft, B. et al., Evaluation of different models of experimentally induced liver cirrhosis for MRI research with correlation to histopathologic findings, Invest Radiol., 34, 360, 1999.
14. Towner, R. A. et al., In vivo assessment of nodularin-induced hepatotoxicity in the rat using magnetic resonance techniques (MRI, MRS and EPR oximetry), Chem. Biol. Interact., 139, 231, 2002.
15. Hockings, P. D. et al., Rapid reversal of hepatic steatosis, and reduction of muscle triglyceride, by rosiglitazone: MRI/S studies in Zucker fatty rats, Diabetes Obes. Metab., 5, 234, 2003.
16. Hockings, P. D. et al., Longitudinal magnetic resonance imaging quantitation of rat liver regeneration after partial hepatectomy, Toxicol. Pathol., 30, 606, 2002.
17. Bambach, G. A., Penney, D. G., and Negendank, W. G., In situ assessment of the rat heart during chronic carbon monoxide exposure using nuclear magnetic resonance imaging, J. Appl. Toxicol., 11, 43, 1991.
18. Jensen, P. D. et al., Indirect evidence for the potential ability of magnetic resonance imaging to evaluate the myocardial iron content in patients with transfusional iron overload, MAGMA., 12, 153, 2001.
19. Hockings, P. D. et al., Validation of MRI measurement of cardiac output in the dog: the effects of dobutamine and minoxidil, Toxicol. Mech. Methods, 13, 39, 2003.
20. Iaina, A., Abrashkin, S., and Weininger, J., Proton MR study of different types of experimental acute renal failure in rats, Magn. Reson. Imaging, 4, 241, 1986.
21. Finney, J. S. et al., The application of proton nuclear magnetic resonance imaging for the in vivo characterisation of chemically induced renal lesions in rats over a prolonged time study, Magn. Reson. Imaging, 8, 713, 1990.
22. Farmer, T. H. et al., Implanted coil MR microscopy of renal pathology, Magn. Reson. Med., 10, 310, 1989.
23. Prasad, P. V. et al., Changes in intrarenal oxygenation as evaluated by BOLD MRI in a rat kidney model for radiocontrast nephropathy, J. Magn. Reson. Imaging, 13, 744, 2001.
24. Laissy, J. P. et al., Reversibility of experimental acute renal failure in rats: assessment with USPIOenhanced MR imaging, J. Magn. Reson. Imaging, 12, 278, 2000.
25. Beckmann, N. et al., Pulmonary edema induced by allergen challenge in the rat: noninvasive assessment by magnetic resonance imaging, Magn. Reson. Med., 45, 88, 2001.
26. Tigani, B. et al., Pulmonary inflammation monitored noninvasively by MRI in freely breathing rats, Biochem. Biophys. Res. Commun., 292, 216, 2002.
27. Beckmann, N. et al., Noninvasive detection of endotoxin-induced mucus hypersecretion in rat lung by MRI, Am. J. Physiol. Lung Cell Mol. Physiol., 283, L22, 2002.
28. Shioya, S. et al., Acute and repair stage characteristics of magnetic resonance relaxation times in oxygen-induced pulmonary edema, Magn. Reson. Med., 8, 450, 1988.
29. Taylor, C. R. et al., Proton relaxation times in bleomycin-induced lung injury, Invest. Radiol., 22, 621, 1987.
30. Suga, K. et al., Altered clearance of gadolinium diethylenetriaminepentaacetic acid aerosol from bleomycin-injured dog lungs: initial observations, Am. J. Respir. Crit. Care Med., 167, 1704, 2003.
31. Kersjes, W. et al., Differentiation of alveolitis and pulmonary fibrosis in rabbits with magnetic resonance imaging after intrabronchial administration of bleomycin 2, Invest. Radiol., 34, 13, 1999.
32. Brasch, R. C. et al., Pulmonary oxygen toxicity: demonstration of abnormal capillary permeability using contrast-enhanced MRI, Pediatr. Radiol., 23, 495, 1993.
33. Chen, X. J. et al., Detection of emphysema in rat lungs by using magnetic resonance measurements of 3He diffusion, Proc. Natl. Acad. Sci. U.S.A, 97, 11478, 2000.
34. Ward, E. R. et al., Proton and hyperpolarized helium magnetic resonance imaging of radiation-induced lung injury in rats, Int. J. Radiat. Oncol. Biol. Phys., 58, 1562, 2004.
35. Bhagat, Y. A. et al., Magnetic resonance imaging predicts neuropathology from soman-mediated seizures in the rodent, Neuroreport, 12, 1481, 2001.
36. Williams, R. E. et al., MRI studies of the neurotoxic effects of L-2-chloropropionic acid on rat brain, Magn. Reson. Imaging, 19, 133, 2001.
37. von Euler, M. et al., Inhalation of low concentrations of toluene induces persistent effects on a learning retention task, beam-walk performance, and cerebrocortical size in the rat, Exp. Neurol., 163, 1, 2000.
38. Gonzalez, H. et al., Progressive multifocal leukoencephalitis (PML) in three patients treated with standard-dose fludarabine (FAMP), Hematol. Cell Ther., 41, 183, 1999.
39. Shbarou, R. M., Chao, N. J., and Morgenlander, J. C., Cyclosporin A-related cerebral vasculopathy, Bone Marrow Transplant., 26, 801, 2000.
40. Thuomas, K. A. et al., MR imaging in solvent-induced chronic toxic encephalopathy, Acta Radiol., 37, 177, 1996.
41. Bernsen, H. J. et al., Magnetic resonance studies on brain dysfunction induced by organic solvents, Acta Neurol. Belg., 92, 207, 1992.
42. Jackson, G. D. et al., Vigabatrin-induced lesions in the rat brain demonstrated by quantitative magnetic resonance imaging, Epilepsy Res., 18, 57, 1994.
43. Eto, K. et al., Methylmercury poisoning in common marmosets-a study of selective vulnerability within the cerebral cortex, Toxicol. Pathol., 29, 565, 2001.
44. Kinoshita, Y. et al., Apparent diffusion coefficient on rat brain and nerves intoxicated with methylmercury, Environ. Res., 80, 348, 1999.
45. Uno, H. et al., Neurotoxicity of glucocorticoids in the primate brain, Horm. Behav., 28, 336, 1994.
46. van Nesselrooij, J. H. et al., Magnetic resonance imaging compared with hormonal effects and histopathology of estrogen-induced pituitary lesions in the rat, Carcinogenesis, 12, 289, 1991.
47. van Nesselrooij, J. H. et al., Rat pituitary changes observed with magnetic resonance imaging following removal of estrogen stimulus: correlation with histopathology and immunohistology, Carcinogenesis, 13, 277, 1992.
48. Peyster, R. G. et al., Use of ex vivo magnetic resonance imaging to detect onset of vigabatrin-induced intramyelinic edema in canine brain, Epilepsia, 36, 93, 1995.
49. Lester, D. S. et al., Virtual neuropathology: three-dimensional visualization of lesions due to toxic insult, Toxicol. Pathol., 28, 100, 2000.
50. Lester, D. S. et al., 3-Dimensional visualization of lesions in rat brain using magnetic resonance imaging microscopy, Neuroreport, 10, 737, 1999.
51. Krestin, G. P., Steinbrich, W., and Friedmann, G., Adrenal masses: evaluation with fast gradient-echo MR imaging and Gd-DTPA-enhanced dynamic studies, Radiology, 171, 675, 1989.
52. Krestin, G. P., Genitourinary MR: kidneys and adrenal glands, Eur. Radiol., 9, 1705, 1999.
53. Yamada, T. et al., Adrenal carcinoma with a signal loss on chemical shift magnetic resonance imaging, J. Comput. Assist. Tomogr., 27, 606, 2003.
54. Llabres-Diaz, F. J. and Dennis, R., Magnetic resonance imaging of the presumed normal canine adrenal glands, Vet. Radiol. Ultrasound, 44, 5, 2003.
55. Beckmann, N. et al., Non-invasive, quantitative assessment of the anatomical phenotype of corticotropin-releasing factor-overexpressing mice by MRI, NMR Biomed., 14, 210, 2001.
56. Sugimoto, M. et al., Availability of NMR microscopic observation of mouse embryo disorder: examination in malformations induced by maternal administration of retinoic acid, J. Vet. Med. Sci., 64, 427, 2002.
57. Wilson, D. et al., Magnetic resonance imaging and morphometric quantitation of cartilage histology after chronic infusion of interleukin 1 in rabbit knees, Proc. Soc. Exp. Biol. Med., 203, 30, 1993.
58. Gough, A. et al., Quinolone arthropathy in immature rabbits treated with the fluoroquinolone, PD 117596, Exp. Toxicol. Pathol., 48, 225, 1996.
59. Yabe, K. et al., Diagnosis of quinolone-induced arthropathy in juvenile dogs by use of magnetic resonance (MR) imaging, J. Vet. Med. Sci., 59, 597, 1997.
60. Mori, K. et al., Magnetic resonance imaging of the galactosemic dog eye using magnetization transfer contrast, Curr. Eye Res., 14, 1035, 1995.
61. Kanikkannan, N., Locke, B. R., and Singh, M., Effect of jet fuels on the skin morphology and irritation in hairless rats, Toxicology, 175, 35, 2002.
62. Johnson, G. A. et al., Magnetic resonance imaging of hepatic neoplasms in the rat, Vet. Pathol., 26, 303, 1989.
63. Bachmann, R. et al., Enhanced tumor detection in the presence of liver cirrhosis: experimental study on the diagnostic value of a superparamagnetic iron oxide MR imaging contrast agent (NSR 0430), J. Magn. Reson. Imaging, 9, 251, 1999.
64. Robinson, S. P. et al., Tumor vascular architecture and function evaluated by non-invasive susceptibility MRI methods and immunohistochemistry, J. Magn. Reson. Imaging, 17, 445, 2003.
65. Johnson, G. A. et al., Morphologic phenotyping with MR microscopy: the visible mouse, Radiology, 222, 789, 2002.